Barcode issues disrupting pharmacy work at more than half of NHS trusts A survey has also revealed that nearly two-thirds of respondents reported that they received medicines without barcodes in the previous month.…
Virtual reality holds the promise of filling medicines manufacturing workforce gaps Will virtual reality technology enable the UK to meet the demands of training in the pharmaceutical industry and medicines manufacturing.…
How pharmacists are storing medicines in soaring temperatures What is being done to ensure hospitals can store medicines safely as heatwaves become more prevalent and what steps are pharmacists taking to maintain medicines integrity in the short term?…
Around one in five adults would share weight-loss jabs with friends, survey finds A Pharmacy2U-commissioned survey also found that more than one-quarter of UK adults said that they would share oral weight-loss medication with friends or family.…
More than 1 million contraception appointments delivered by pharmacies in six months The 1,007,415 pharmacy contraception service consultations included 375,040 emergency hormonal contraception consultations.…
Post-finasteride syndrome: pharmacists must lead the conversation on patient safety We would not accept a tooth-whitening procedure that carried a risk of suicide, persistent sexual dysfunction and irreversible neurological harm. Why is it being accepted with finasteride?…
Health news round-up: coffee, ADHD prescribing, and GLP-1s and hair loss The Pharmaceutical Journal’s weekly summary of the important developments in pharmacy and health news you may have missed.…
Everything you need to know about clinical trial legislation changes Clinical trial legislation has been overhauled to speed up set-up times and include a broader range of healthcare professionals, but what do the reforms mean for patients and pharmacists?…
Novo Nordisk sues Eli Lilly over ‘misleading’ GLP-1 advertising Novo Nordisk claims that Lilly’s advertising campaigns intentionally used outdated studies to offer “proof of broad, product-level superiority” of its Zepbound and Mounjaro products over Novo Nordisk’s Wegovy and Ozempic products.…
PJ view: Patients deserve a regulatory system built to keep them safe as oral semaglutide launches Regulators have taken welcome steps to tackle counterfeit weight-loss medicines, but patients cannot be left to police this market alone.…
